Indivior



Ebitda Cambiamento Data
AstraZeneca USD 5.26B 597M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Indivior 9M 92M 2024-09
J&J USD 7.88B 1.76B 2025-03
Kyowa Hakko Kirin JPY 33.23B 2.39B 2024-09
Merck USD 7.12B 1.06B 2024-12
Novartis USD 6.82B 1.31B 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Sanofi EUR 563M 3.93B 2024-12
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12



Indivior - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.